ZTS News and Press, Zoetis Inc. Class A

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:05 p.m. ET. Investors and other interes...

2024-05-15 09:00:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. U.S. economic growth remained positive...

2024-05-15 08:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Prestigious honor recognizes Zoetis as a leading U.S. company for workplace fairness in talent strategies, workplace and supplier diversity practices and philanthropic engagement Zoetis also recognized on three Fair360 specialty lists, including Top Companies for Women Executives, Top Com...

2024-05-13 04:06:09 ET Summary I have been focused on accumulating shares of blue chip compounders with market-beating returns and increasing passive income. I have reduced my holding count from 85 stocks/funds to 70 and have become more concentrated in my highest conviction ideas...

2024-05-11 08:45:37 ET More on IDEXX Laboratories IDEXX Laboratories, Inc. (IDXX) Q1 2024 Earnings Call Transcript IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade) IDEXX Laboratories reports mixed Q1 results; updates FY24 ...

2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can  compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...

2024-05-08 23:00:50 ET Summary William von Mueffling's 13F portfolio value increased by approximately 6% to $15.90B in Q1 2024. The top five positions in the portfolio are Broadcom, S&P Global, Alphabet, Applied Materials, and Visa. New stakes were established in Yum Brand...

2024-05-05 09:52:16 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Dovish Fed, 'Goldilocks' jobs report helps S&P 500 notch back-to-back weekly gains...

2024-05-03 14:37:00 ET Summary Zoetis is a leader in animal health, focusing on R&D to develop innovative medicines and technologies for pets and livestock. Concerns have arisen about the safety of their drugs, but Zoetis appears confident and reported impressive revenue growt...